ReviewAngewandte Chemie (International ed. in English)2025
Inter-Nanoparticle FRET for Biosensing: Photophysics Versus Size.
Review in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Click'n ROPISA: One-Pot Synthesis of Ultrabright Fluorescent Nanoparticles Made of Polypeptides.Angewandte Chemie (International ed. in English) · 2026Article
- Near-infrared light-controlled catalytic hairpin assembly fluorescent biosensor for the sensitive and specific detection of fibroblast activation protein.Nanoscale advances · 2026Article
- Tailoring Photonic Landscape: Nanoengineering Empowers NIR-II Lanthanide Luminescence for Versatile Biomedical Applications.Small methods · 2026Review
- Modularized GSH-Proton Tandem-Responsive "Off-Brighter" Persistent Luminescent Nano-System for Visualized Synergetic PTT & CDT of Mastocarcinoma.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Optimization of Fluorescent Nanoparticles Architecture for Efficient Brightness, FRET Efficiency and Biosensing.Small methods · 2026Article
- Artificial Gap Junctional Channel Inhibiting the Proliferation of Hepatocellular Carcinoma Cells.Angewandte Chemie (International ed. in English) · 2026Article
- Dual-targeted hybrid nanovesicles coordinated bone-muscle regeneration via regulating the DUSP4/p38 MAPK pathway to reverse osteosarcopenia.Journal of nanobiotechnology · 2026Article
- Inter-Nanoparticle FRET for Biosensing: Photophysics Versus Size.Angewandte Chemie (International ed. in English) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Förster resonance energy transfer (FRET) enables the quantification of nanoscale distances and biomolecular interactions. Luminescent nanoparticles (NPs) are frequently combined with fluorescent dyes or proteins in FRET. However, their use in inter-NP FRET with luminescent NPs as both donor and acceptor remains less common due to the inherent size constraints that can limit FRET efficiencies. This review critically examines the early advances and current state-of-the-art of inter-NP FRET with a focus on the most commonly used NPs, namely quantum dots (QDs), upconversion nanoparticles (UCNPs), and fluorescent organic nanoparticles (FONs). We show how NP sizes, surface shells, and coatings increase FRET-distances; propose how these drawbacks can be overcome or outcompeted by the unique photophysical properties of the NPs; and discuss representative examples of inter-NP FRET for biosensing. High luminescence brightness, outstanding photostability, near-infrared excitation and emission, spectral and temporal multiplexing, and large surfaces for multifunctional bioconjugation are only some of the features that make luminescent NPs very attractive for biosensing, and FRET efficiencies up to 90% have demonstrated their potential for successful translation into bioanalytical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.